Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 361-367

  Gastl, Gunther ^b   Ebert, Thomas ^b   Finstad, Connie L ^b   Sheinfeld, Joel ^b   Gomahr, Andreas ^b   Aulitzky, Wolfgang ^b   Bander, Neil H ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

Beta 2 microglobulin; Interferon type II; Kidney neoplasms; Major histocompatibility complex

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; METASTASIS; PRIORITY JOURNAL; TUMOR GROWTH;

BETA 2-MICROGLOBULIN; CARCINOMA, RENAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HLA ANTIGENS; HLA-D ANTIGENS; HUMAN; IMMUNOENZYME TECHNIQUES; INTERFERON-GAMMA, RECOMBINANT; KIDNEY; KIDNEY NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0029655529     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66661-8     Document Type: Article

References (36)

1. Zinkernagel, R. M. and Doherty, P. C.: MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction: specificity, function, and responsiveness. Adv. Immunol., 27: 51, 1979.
2. Elliott, B. E., Carlow, D. A., Rodricks, A. M. and Wade, A.: Perspectives on the role of MHC antigens in normal and malignant cell development. Adv. Cancer Res., 53: 181, 1989.
3. Lopez-Nevot, M. A., Garcia, E., Pareja, E., Bonal, F. J., Martin, J., Ruiz-Cabello, F., Serrano, S. and Garrido, F.: Differential expression of HLA class I and II antigens in primary and metastatic melanomas. J. Immunogenet., 13: 219, 1986.
4. Momburg, F., Degener, T., Bacchus, E., Moldenhauer, G., Hammerling, G. J. and Moller, P.: Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer. Int. J. Cancer, 37: 179, 1986.
5. Hui, K., Grosveld, F. and Festenstein, H.: Rejection of transplantable AKR leukemia cells following MHC DNA-mediated cell transformation. Nature, 311: 750, 1984.
6. Hayashi, H., Tanaka, K., Jay, F., Khoury, G. and Jay, G.: Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon. Cell, 43: 263, 1985.
7. Tanaka, K., Isselbacher, K. J., Khoury, G. and Jay, G.: Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science, 228: 26, 1985.
8. Ostrand-Rosenberg, S., Thakur, A. and Clements, V.: Rejection of mouse sarcoma cells after transfection of MHC class II genes. J. Immunol., 144: 4068, 1990.
9. Trinchieri, G. and Perussia, B.: Immune interferon: a pleotropic lymphokine with multiple effects. Immunol. Today, 6: 131, 1985.
10. Aulitzky, W., Gastl, G., Aulitzky, W. E., Herold, M., Kemmler, J., Mull, B., Frick, J. and Huber, C.: Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma. J. Clin. Oncol., 7: 1875, 1989.
11. Ellerhorst, J., Jones, E., Kilbourn, R., Sella, A., Amato, R., Zukiwski, A. and Logothetis, C.: Fixed low dose gamma interferon (IFN) is active against metastatic renal cell carcinoma (RCC). Proc. Am. Soc. Clin. Oncol., 11: 220, 1993.
12. Ebert, T., Bander, N. H., Finstad, C. L., Ramsawak, R. D. and Old, L. J.: Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res., 50: 5531, 1990.
13. Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J. and Bodmer, W. F.: Monoclonal antibodies for analysis of the HLA system. Immunol. Rev., 47: 3, 1979.
14. Houghton, A. N., Thomson, T. M., Gross, D., Oettgen, H. F. and Old, L. J.: Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon. J. Exp. Med., 160: 255, 1984.
15. Gastl, G., Finstad, C. L., Guarini, A., Bosl, G., Gilboa, E., Bander, N. H. and Gansbacher, B.: Retroviral-vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res., 52: 6229, 1992.
16. Finstad, C. L., Cordon-Cardo, C., Bander, N. H., Whitmore, W. F., Melamed, M. R. and Old, L. J.: Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc. Natl. Acad. Sci. U.S.A., 82: 2955, 1985.
17. Bander, N. H., Finstad, C. L., Cordon-Cardo, C., Ramsawak, R. D., Vaughan, E. D., Jr., Whitmore, W. F., Jr., Oettgen, H. F., Melamed, M. R. and Old, L. J.: Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res., 49: 6774, 1989.
18. Natali, P. G., Bigotti, A., Nicotra, M. R., Viora, M., Manfredi, D. and Ferrone, S.: Distribution of human class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of non-lymphoid origin. Cancer Res., 44: 4679, 1984.
19. Cordon-Cardo, C., Fuks, Z., Drobnjak, M., Moreno, C., Eisenbach, L. and Feldman, M.: Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res., 51: 6372, 1991.
20. Heinemann, D., Smith, P. J. and Symes, M. O.: Expression of histocompatibility antigens and characterizations of mononuclear cell infiltrates in human renal cell carcinoma. Br. J. Cancer, 56: 433, 1987.
21. Buszello, H. and Ackermann, R.: Expression of HLA class-I antigens on renal cell carcinoma and non-transformed renal tissue. Eur. Urol., 21: 70, 1992.
22. Tomita, Y., Nishiyama, T., Fujiwara, M. and Sato, S.: Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumor-infiltrating mononuclear cells in renal cell cancer. Br. J. Cancer, 62: 354, 1990.
23. Droz, D., Zachar, D., Charbit, L., Gogusev, J., Chretien, Y. and Iris, L.: Expression of the human nephron differentiation molecules in renal cell carcinomas. Am. J. Pathol., 137: 895, 1990.
24. Angus, R., Collins, C. M. and Symes, M. O.: Expression of major histocompatibility complex (MHC) antigens and their loss on culture in renal cell carcinoma. Eur. J. Cancer, 29A: 2158, 1993.
25. Marincola, F. M., Shamamian, T. B., Abati, A., Hackett, J., O'Dea, T., Fetsch, P., Yanelli, J., Restifo, N. P., Mule, J. J. and Rosenberg, S. A.: Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. J. Immunother., 16: 13, 1994.
26. Natali, P. G., Nicotra, M. R., Bigotti, A., Venturo, I., Marcenaro, L., Giacomini, P. and Russo, C.: Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc. Natl. Acad. Sci. U.S.A., 86: 6719, 1989.
27. Goepel, J. R., Rees, R. C., Rogers, K., Stoddard, C. J., Thomas, W. E. G. and Shepherd, L.: Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon cancer. Br. J. Cancer, 64: 880, 1991.
28. Kageshita, T., Wang, Z., Calorini, L., Kimura, T., Ono, T., Gattoni-Celli, S. and Ferrone, S.: Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res., 53: 3349, 1993.
29. Schrier, P. I. and Peltenberg, L. T. C.: Relationship between myc oncogene activation and MHC class I expression. Adv. Cancer Res., 60: 181, 1993.
30. Restifo, N. P., Esquivel, F., Kawarami, Y., Yedwell, J. W., Mule, J. J., Rosenberg, S. A. and Bennink, J. R.: Identification of human cancers deficient in antigen processing. J. Exp. Med., 177: 265, 1993.
31. D'Urso, C. M., Wang, Z., Cao, Y., Tatake, R., Zeff, R. A. and Ferrone, S.: Lack of HLA class I antigen expression. J. Clin. Invest., 87: 284, 1991.
32. Wang, Z., Cao, Y., Albino, A. P., Zeff, R. A., Houghton, A. N. and Ferrone, S.: Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in β2-microglobulin messenger RNA. J. Clin. Invest., 91: 684, 1993.
33. Fuggle, S. V., Errasti, P., Daar, A. S., Fabre, J. W., Ting, A. and Morris, P. J.: Localization of major histocompatibility complex (HLA-A,B,C and DR) antigens in 46 kidneys. Transplantation, 35: 385, 1983.
34. Hall, B., M., Bishop, G. A., Duggin, G. G., Horvath, J. S., Philips, J. and Tiller, D. J.: Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet, II: 247, 1984.
35. Halloran, P. F., Autenried, P. and Wadgymar, A.: Regulation of HLA antigen expression in human kidney. Clin. Immunol. Allergy, 6: 411, 1986.
36. Graham, S. D.: Immunotherapy of renal cell carcinoma. Semin. Urol., 7: 215, 1989.